UBS AG Reaffirms Sell Rating for Owens & Minor, Inc. (NYSE:OMI)

UBS AG reiterated their sell rating on shares of Owens & Minor, Inc. (NYSE:OMI) in a report issued on Wednesday morning, www.flashratings.com reports. They currently have a $29.50 price target on the stock, down from their previous price target of $30.50.

A number of other equities analysts have also commented on the stock. Zacks Investment Research lowered shares of Owens & Minor from a hold rating to a sell rating in a research report on Friday, May 5th. TheStreet lowered shares of Owens & Minor from a b rating to a c+ rating in a research report on Thursday, May 4th. BidaskClub lowered shares of Owens & Minor from a hold rating to a sell rating in a research report on Tuesday, June 20th. Finally, Jefferies Group LLC set a $36.00 price target on shares of Owens & Minor and gave the company a hold rating in a research report on Monday, May 22nd. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and one has assigned a buy rating to the company. Owens & Minor has a consensus rating of Hold and an average price target of $31.88.

Shares of Owens & Minor (NYSE OMI) opened at 28.25 on Wednesday. The company has a market cap of $1.73 billion, a PE ratio of 17.97 and a beta of 1.01. Owens & Minor has a 12-month low of $27.98 and a 12-month high of $37.02. The stock’s 50 day moving average price is $31.26 and its 200-day moving average price is $33.38.

Owens & Minor (NYSE:OMI) last released its quarterly earnings results on Tuesday, August 1st. The company reported $0.43 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.43. The firm had revenue of $2.27 billion for the quarter, compared to analyst estimates of $2.38 billion. Owens & Minor had a net margin of 1.02% and a return on equity of 11.64%. The company’s revenue for the quarter was down 8.8% compared to the same quarter last year. During the same period in the previous year, the business earned $0.52 earnings per share. On average, equities research analysts forecast that Owens & Minor will post $1.92 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “UBS AG Reaffirms Sell Rating for Owens & Minor, Inc. (NYSE:OMI)” was originally published by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this piece of content on another website, it was copied illegally and reposted in violation of international copyright & trademark laws. The original version of this piece of content can be accessed at https://transcriptdaily.com/2017/08/13/ubs-ag-reaffirms-sell-rating-for-owens-minor-inc-nyseomi.html.

The company also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Shareholders of record on Friday, September 15th will be given a $0.2575 dividend. The ex-dividend date is Thursday, September 14th. This represents a $1.03 dividend on an annualized basis and a yield of 3.65%. Owens & Minor’s dividend payout ratio (DPR) is presently 65.19%.

In other news, EVP Rony Camil Kordahi sold 2,231 shares of the company’s stock in a transaction that occurred on Wednesday, May 24th. The shares were sold at an average price of $32.07, for a total transaction of $71,548.17. Following the transaction, the executive vice president now directly owns 27,555 shares in the company, valued at $883,688.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Erika T. Davis sold 9,317 shares of the company’s stock in a transaction that occurred on Tuesday, May 23rd. The stock was sold at an average price of $32.26, for a total transaction of $300,566.42. Following the transaction, the senior vice president now owns 63,979 shares in the company, valued at $2,063,962.54. The disclosure for this sale can be found here. 1.68% of the stock is owned by insiders.

Institutional investors have recently made changes to their positions in the company. Bank of Montreal Can raised its position in shares of Owens & Minor by 1.0% in the first quarter. Bank of Montreal Can now owns 34,212 shares of the company’s stock worth $1,183,000 after buying an additional 343 shares during the last quarter. Fox Run Management L.L.C. bought a new position in shares of Owens & Minor during the first quarter worth about $284,000. CWM LLC raised its position in shares of Owens & Minor by 15.5% in the first quarter. CWM LLC now owns 709,335 shares of the company’s stock worth $24,543,000 after buying an additional 95,023 shares during the last quarter. Dean Capital Management bought a new position in shares of Owens & Minor during the first quarter worth about $2,283,000. Finally, Macquarie Group Ltd. raised its position in shares of Owens & Minor by 2.3% in the first quarter. Macquarie Group Ltd. now owns 1,272,360 shares of the company’s stock worth $44,024,000 after buying an additional 29,095 shares during the last quarter. Institutional investors own 96.05% of the company’s stock.

About Owens & Minor

Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).

Receive News & Ratings for Owens & Minor Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Owens & Minor Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply